Citations (105)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Kerul Marsonia, Kedarisetti Kiran Chandra, M. Hasnat Ali, Jay Chhablani & Raja Narayanan. (2022) Long term follow-up of visual acuity and incidence of subretinal neovascularization in Mactel Type 2 in 82 Eyes. Seminars in Ophthalmology 37:2, pages 136-141.
Read now
Read now
Young Ho Kim, Yoo-Ri Chung, Jaeryung Oh, Seong-Woo Kim, Christopher Seungkyu Lee, Cheolmin Yun, Boram Lee, So Min Ahn, Eun Young Choi, Sungmin Jang & Kihwang Lee. (2021) Demographic and Multimodal Imaging Features of Macular Telangiectasia Type 2: Korean Macular Telangiectasia Type 2 Study – Report No. 2. Ophthalmic Epidemiology 28:5, pages 436-443.
Read now
Read now
Gokhan Demir, Ihsan Cakir, Zeynep Alkin, Ali Demircan, Beril Tulu & Korhan Fazıl. (2020) Evaluation of Choroidal Thickness in Patients with Proliferative and Non-Proliferative Macular Telangiectasia Using Enhanced Depth Imaging Optical Coherence Tomography. Current Eye Research 45:4, pages 504-508.
Read now
Read now
Anagha Vaze & Mark Gillies. (2016) Salient features and management options of macular telangiectasia type 2: a review and update. Expert Review of Ophthalmology 11:6, pages 429-441.
Read now
Read now
Traci E. Clemons, Mark C. Gillies, Emily Y. Chew, Alan C. Bird, Tunde Peto, Jie Jin Wang, Paul Mitchell, Wishal D. Ramdas & Johannes R. Vingerling. (2013) Medical Characteristics of Patients with Macular Telangiectasia Type 2 (MacTel Type 2) MacTel Project Report No. 3. Ophthalmic Epidemiology 20:2, pages 109-113.
Read now
Read now
Emily Y. Chew. (2012) How Prevalent is Macular Telangiectasia Type 2?. Ophthalmic Epidemiology 19:4, pages 183-184.
Read now
Read now
Ferenc B. Sallo, Irene Leung, Wanjiku Mathenge, Fatima Kyari, Hannah Kuper, Clare E. Gilbert, Alan C. Bird & Tunde Peto. (2012) The Prevalence of Type 2 Idiopathic Macular Telangiectasia in Two African Populations. Ophthalmic Epidemiology 19:4, pages 185-189.
Read now
Read now
Articles from other publishers (98)
Lihteh Wu. (2023) Unraveling the mysteries of macular telangiectasia 2: the intersection of philanthropy, multimodal imaging and molecular genetics. The 2022 founders lecture of the pan American vitreoretinal society. International Journal of Retina and Vitreous 9:1.
Crossref
Crossref
Kiyoto Totsuka, Shuichiro Aoki, Takahiro Arai, Kodai Kitamoto, Keiko Azuma, Ryosuke Fujino, Tatsuya Inoue & Ryo Obata. (2023) Longitudinal anatomical and visual outcome of macular telangiectasia type 2 in Asian patients. Scientific Reports 13:1.
Crossref
Crossref
Marina Yasvoina, Qian Yang, Sasha M Woods, Tjebo Heeren, Grant M. Comer, Catherine A. Egan & Marcus Fruttiger. (2023) Intraretinal pigmented cells in retinal degenerative disease. British Journal of Ophthalmology 107:11, pages 1736-1743.
Crossref
Crossref
Michal K. HandzlikChristian M. Metallo. (2023) Sources and Sinks of Serine in Nutrition, Health, and Disease. Annual Review of Nutrition 43:1, pages 123-151.
Crossref
Crossref
Emily Y. Chew, Tunde Peto, Traci E. Clemons, Ferenc B. Sallo, Daniel Pauleikhoff, Irene Leung, Glenn J. Jaffe, Tjebo F.C. Heeren, Catherine A. Egan, Peter Charbel Issa, Konstantinos Balaskas, Frank G. Holz, Alain Gaudric, Alan C. Bird & Martin Friedlander. (2023) Macular Telangiectasia Type 2. Ophthalmology Science 3:2, pages 100261.
Crossref
Crossref
Kevin T. Eade, Brendan Robert E. Ansell, Sarah Giles, Regis Fallon, Sarah Harkins-Perry, Takayuki Nagasaki, Simone Tzaridis, Martina Wallace, Elizabeth A. Mills, Samaneh Farashi, Alec Johnson, Lydia Sauer, Barbara Hart, M. Elena Diaz-Rubio, Melanie Bahlo, Christian Metallo, Rando Allikmets, Marin L. Gantner, Paul S. Bernstein & Martin Friedlander. (2023) iPSC–derived retinal pigmented epithelial cells from patients with macular telangiectasia show decreased mitochondrial function. Journal of Clinical Investigation 133:9.
Crossref
Crossref
Kristina Hess, Yu Jeong Park, Hyun-Ah Kim, Frank G. Holz, Peter Charbel Issa, Young Hee Yoon & Simone Tzaridis. (2023) Tamoxifen Retinopathy and Macular Telangiectasia Type 2. Ophthalmology Retina 7:2, pages 101-110.
Crossref
Crossref
Kristina Hess, Peter Charbel Issa, Frank G Holz & Simone Tzaridis. (2022) Morphological characteristics preceding exudative neovascularisation secondary to macular telangiectasia type 2. British Journal of Ophthalmology 106:12, pages 1736-1741.
Crossref
Crossref
Andrew J. Mangum. (2022) Macular Telangiectasia Type 2: Case Report and Clinical Review. CRO (Clinical & Refractive Optometry) Journal 33:2.
Crossref
Crossref
. 2022. The Fovea. The Fovea
187
241
.
Andreas Bringmann & Peter Wiedemann. 2022. The Fovea. The Fovea
139
185
.
Mary E. Aronow & Joan W. Miller. 2022. Albert and Jakobiec's Principles and Practice of Ophthalmology. Albert and Jakobiec's Principles and Practice of Ophthalmology
3815
3831
.
Roberto Bonelli, Brendan R. E. Ansell, Luca Lotta, Thomas Scerri, Traci E. Clemons, Irene Leung, Tunde Peto, Alan C. Bird, Ferenc B. Sallo, Claudia Langenberg & Melanie Bahlo. (2021) Genetic disruption of serine biosynthesis is a key driver of macular telangiectasia type 2 aetiology and progression. Genome Medicine 13:1.
Crossref
Crossref
Saskia H.M. van Romunde, Charlotte M. van der Sommen, José P. Martinez Ciriano, Johannes R. Vingerling & Suzanne Yzer. (2021) Prevalence and Severity of Diabetic Retinopathy in Patients with Macular Telangiectasia Type 2. Ophthalmology Retina 5:10, pages 999-1004.
Crossref
Crossref
Buğra Karasu & Ali Rıza Cenk Celebi. (2021) Choroidal vascularity index: an enhanced depth optical coherence tomography-based parameter to determine vascular status in patients with proliferative and non-proliferative macular telangiectasia. International Ophthalmology 41:10, pages 3505-3513.
Crossref
Crossref
Simone Tzaridis, Tjebo Heeren, Clarissa Mai, Sarah Thiele, Frank G Holz, Peter Charbel Issa & Philipp Herrmann. (2021) Right-angled vessels in macular telangiectasia type 2. British Journal of Ophthalmology 105:9, pages 1289-1296.
Crossref
Crossref
Yoo-Ri Chung, Young Ho Kim, Jaeryung Oh, Seong-Woo Kim, Christopher Seungkyu Lee, Cheolmin Yun, Boram Lee, So Min Ahn, Eun Young Choi, Sungmin Jang & Kihwang Lee. (2021) Characterizing right-angled vessel in macular telangiectasia type 2 with structural optical coherence tomography. Scientific Reports 11:1.
Crossref
Crossref
Laurenz Pauleikhoff, Tjebo F.C. Heeren, Martin Gliem, Ernest Lim, Daniel Pauleikhoff, Frank G. Holz, Traci Clemons, Konstantinos Balaskas, Catherine A. Egan & Peter Charbel Issa. (2021) Fundus Autofluorescence Imaging in Macular Telangiectasia Type 2: MacTel Study Report Number 9. American Journal of Ophthalmology 228, pages 27-34.
Crossref
Crossref
Sumit Randhir Singh, Samantha Fraser-Bell, Avantika Dogra, Niroj Kumar Sahoo, Pierre-Henry Gabrielle, Marco Lupidi, Mayss Al-Sheikh, Enrico Borrelli, Riccardo Sacconi, Giuseppe Querques & Jay Chhablani. (2020) Optical coherence tomography angiography findings of fellow eye of proliferative macular telangiectasia type 2: Long term study. European Journal of Ophthalmology 31:4, pages 1933-1939.
Crossref
Crossref
Simone TzaridisKristina HessTjebo F. C. HeerenRoberto BonelliFrank G. HolzMartin Friedlander. (2021) HYPERREFLECTIVITY ON OPTICAL COHERENCE TOMOGRAPHY IN MACULAR TELANGIECTASIA TYPE 2. Retina 41:7, pages 1428-1437.
Crossref
Crossref
Lydia Sauer, Alexandra S. Vitale, Natalie K. Modersitzki & Paul S. Bernstein. (2021) LONGITUDINAL FLUORESCENCE LIFETIME IMAGING OPHTHALMOSCOPY ANALYSIS IN PATIENTS WITH MACULAR TELANGIECTASIA TYPE 2 (MacTel). Retina 41:7, pages 1416-1427.
Crossref
Crossref
Valérie Krivosic, Carlo Lavia, Anais Aubineau, Ramin Tadayoni & Alain Gaudric. (2021) OCT of Outer Retinal Hyperreflectivity, Neovascularization, and Pigment in Macular Telangiectasia Type 2. Ophthalmology Retina 5:6, pages 562-570.
Crossref
Crossref
Simone Tzaridis, Kristina Hess, Martin Friedlander & Frank G Holz. (2021) Optical coherence tomography-angiography for monitoring neovascularisations in
macular telangiectasia type 2. British Journal of Ophthalmology 105:5, pages 735-740.
Crossref
Crossref
Akihiro Shinkai, Wataru Saito, Yuki Hashimoto, Michiyuki Saito, Satoru Kase, Kousuke Noda & Susumu Ishida. (2020) Morphological features of macular telangiectasia type 2 in Japanese patients. Graefe's Archive for Clinical and Experimental Ophthalmology 259:5, pages 1179-1189.
Crossref
Crossref
Roberto Bonelli, Victoria E. Jackson, Aravind Prasad, Jacob E. Munro, Samaneh Farashi, Tjebo F. C. Heeren, Nikolas Pontikos, Lea Scheppke, Martin Friedlander, Catherine A. Egan, Rando Allikmets, Brendan R. E. Ansell & Melanie Bahlo. (2021) Identification of genetic factors influencing metabolic dysregulation and retinal support for MacTel, a retinal disorder. Communications Biology 4:1.
Crossref
Crossref
Anmar Abdul-Rahman. (2020) Case report: internal limiting membrane drape sign masking by foveal detachment in macular telangiectasia type 2. BMC Ophthalmology 20:1.
Crossref
Crossref
Tjebo F.C. Heeren, Emily Y. Chew, Traci Clemons, Marcus Fruttiger, Konstantinos Balaskas, Roy Schwartz, Catherine A. Egan & Peter Charbel Issa. (2020) Macular Telangiectasia Type 2: Visual Acuity, Disease End Stage, and the MacTel Area. Ophthalmology 127:11, pages 1539-1548.
Crossref
Crossref
Alexander R. Bottini, Barton L. Blackorby, Madelyn Michaels, Katherine Burkett, Sabin Dang, Kevin J. Blinder & Gaurav K. Shah. (2020) Long-Term Outcomes in Macular Telangiectasia Type 2 With Subretinal Neovascularization. Journal of VitreoRetinal Diseases 4:5, pages 386-392.
Crossref
Crossref
Simone TzaridisKristina HessTjebo F. C. HeerenJennifer NadalClarissa MaiPhilipp HerrmannPeter Charbel IssaFrank G. Holz. (2020) DARK ADAPTATION IN MACULAR TELANGIECTASIA TYPE 2. Retina 40:10, pages 2018-2025.
Crossref
Crossref
Lydia Sauer, Alexandra S. Vitale, Karl M. AndersenBarbara Hart & Paul S. Bernstein. (2020) FLUORESCENCE LIFETIME IMAGING OPHTHALMOSCOPY (FLIO) PATTERNS IN CLINICALLY UNAFFECTED CHILDREN OF MACULAR TELANGIECTASIA TYPE 2 (MACTEL) PATIENTS. Retina 40:4, pages 695-704.
Crossref
Crossref
Katie M. Litts, Mali Okada, Tjebo F. C. Heeren, Angelos Kalitzeos, Vincent Rocco, Rebecca R. Mastey, Navjit Singh, Thomas Kane, Melissa Kasilian, Marcus Fruttiger, Michel Michaelides, Joseph Carroll & Catherine Egan. (2020) Longitudinal Assessment of Remnant Foveal Cone Structure in a Case Series of Early Macular Telangiectasia Type 2. Translational Vision Science & Technology 9:4, pages 27.
Crossref
Crossref
Yifan Zhou, Minwen Zhou, Min Gao, Haiyun Liu & Xiaodong Sun. (2020) Factors Affecting the Foveal Avascular Zone Area in Healthy Eyes among Young Chinese Adults. BioMed Research International 2020, pages 1-8.
Crossref
Crossref
Sergio Rojas-Juárez & Paola Brito-Sandoval. (2020) Hallazgos en la angiografía por tomografía de coherencia óptica en pacientes mexicanos con telangiectasias maculares tipo 2. Revista Mexicana de Oftalmología 94:2S, pages 77-82.
Crossref
Crossref
Yasmin SolbergChantal DysliSebastian WolfMartin S. Zinkernagel. (2020) FLUORESCENCE LIFETIME PATTERNS IN MACULAR TELANGIECTASIA TYPE 2. Retina 40:1, pages 99-108.
Crossref
Crossref
Richard F. Spaide. 2020. Macular Disorders. Macular Disorders
73
84
.
Mary E. Aronow & Joan W. Miller. 2020. Albert and Jakobiec's Principles and Practice of Ophthalmology. Albert and Jakobiec's Principles and Practice of Ophthalmology
1
18
.
Daniel Pauleikhoff, Roberto Bonelli, Adam M Dubis, Frederic Gunnemann, Kai Rothaus, Peter Charbel Issa, Tjebo FC Heeren, Tunde Peto, Traci E Clemons, Emily Y Chew, Alan C Bird & Ferenc B Sallo. (2019) Progression characteristics of ellipsoid zone loss in macular telangiectasia type 2. Acta Ophthalmologica 97:7.
Crossref
Crossref
Simone Tzaridis, Philipp Herrmann, Peter Charbel Issa, Simona Degli Esposti, Siegfried K Wagner, Marcus Fruttiger, Catherine Egan, Gary Rubin, Frank G. Holz & Tjebo F. C. Heeren. (2019) Binocular Inhibition of Reading in Macular Telangiectasia Type 2. Investigative Opthalmology & Visual Science 60:12, pages 3835.
Crossref
Crossref
Simone Tzaridis, Maximilian W. M. Wintergerst, Clarissa Mai, Tjebo F. C. Heeren, Frank G. Holz, Peter Charbel Issa & Philipp Herrmann. (2019) Quantification of Retinal and Choriocapillaris Perfusion in Different Stages of Macular Telangiectasia Type 2. Investigative Opthalmology & Visual Science 60:10, pages 3556.
Crossref
Crossref
Alireza Khodabande, Ramak Roohipoor, Javad Zamani, Masoud Mirghorbani, Hamidreza Zolfaghari, Shahab Karami & Bobeck S. Modjtahedi. (2019) Management of Idiopathic Macular Telangiectasia Type 2. Ophthalmology and Therapy 8:2, pages 155-175.
Crossref
Crossref
Tjebo F. C. Heeren, Simone Tzaridis, Roberto Bonelli, Maximilian Pfau, Marcus Fruttiger, Mali Okada, Catherine Egan, Peter Charbel Issa & Frank G. Holz. (2019) Dark-Adapted Two-Color Fundus-Controlled Perimetry in Macular Telangiectasia Type 2. Investigative Opthalmology & Visual Science 60:5, pages 1760.
Crossref
Crossref
Panos G. Christakis, Henry E. Wiley & Howard F. Fine. (2019) The Diagnosis and Management of Macular Telangiectasia. Ophthalmic Surgery, Lasers and Imaging Retina 50:3, pages 139-144.
Crossref
Crossref
Yuka Kihara, Tjebo F. C. Heeren, Cecilia S. Lee, Yue Wu, Sa Xiao, Simone Tzaridis, Frank G. Holz, Peter Charbel Issa, Catherine A. Egan & Aaron Y. Lee. (2019) Estimating Retinal Sensitivity Using Optical Coherence Tomography With Deep-Learning Algorithms in Macular Telangiectasia Type 2. JAMA Network Open 2:2, pages e188029.
Crossref
Crossref
Simone Müller, Tjebo F.C. Heeren, Jennifer Nadal, Peter Charbel Issa, Philipp Herrmann, Frank G. Holz & Bettina K. Wabbels. (2019) Stereoscopic Vision in Macular Telangiectasia Type 2. Ophthalmologica 241:3, pages 121-129.
Crossref
Crossref
Martin G Lee, Nathaniel S Marshall, Traci E Clemons, Michael L Hunter, Alan L James, Ron R Grunstein, Vuong Nguyen, Anna Campain & Mark C Gillies. (2018) No association between sleep apnoea and macular telangiectasia type 2 and its markers of severity and progression: a case–control study and retrospective cohort study. Clinical & Experimental Ophthalmology 47:1, pages 63-68.
Crossref
Crossref
Lydia Sauer & Paul S. Bernstein. 2019. Fluorescence Lifetime Imaging Ophthalmoscopy. Fluorescence Lifetime Imaging Ophthalmoscopy
79
87
.
Paul Bernstein, Chantal Dysli, Jörg Fischer, Martin Hammer, Yoshihiko Katayama, Lydia Sauer & Martin S. Zinkernagel. 2019. High Resolution Imaging in Microscopy and Ophthalmology. High Resolution Imaging in Microscopy and Ophthalmology
213
235
.
Quraish Ghadiali, Orly Gal-Or, Jonathan Naysan, James Klancnik, K. Bailey Freund & SriniVas R. Sadda. (2018) Diagnostic and Therapeutic Challenges. Retina 38:12, pages 2429-2434.
Crossref
Crossref
Simone Müller, Peter Charbel Issa, Tjebo F.C. Heeren, Sarah Thiele, Frank G. Holz & Philipp Herrmann. (2018) Macular Pigment Distribution as Prognostic Marker for Disease Progression in Macular Telangiectasia Type 2. American Journal of Ophthalmology 194, pages 163-169.
Crossref
Crossref
Lydia Sauer. (2018) Review of clinical approaches in fluorescence lifetime imaging ophthalmoscopy. Journal of Biomedical Optics 23:09, pages 1.
Crossref
Crossref
Lydia Sauer, Rebekah H. Gensure, Martin Hammer & Paul S. Bernstein. (2018) Fluorescence Lifetime Imaging Ophthalmoscopy: A Novel Way to Assess Macular Telangiectasia Type 2. Ophthalmology Retina 2:6, pages 587-598.
Crossref
Crossref
Emily Y. Chew & Martin Friedlander. (2018) Global Connections to Study Idiopathic Macular Telangiectasia Type 2. Retina 38:1, pages S3-S7.
Crossref
Crossref
Irene LeungFerenc B. SalloRoberto BonelliTraci E. ClemonsDaniel PauleikhoffEmily Y. ChewAlan C. Bird & Tunde Peto. (2018) CHARACTERISTICS OF PIGMENTED LESIONS IN TYPE 2 IDIOPATHIC MACULAR TELANGIECTASIA. Retina 38:1, pages S43-S50.
Crossref
Crossref
Mali OkadaCatherine A. EganTjebo F. C. Heeren, Adnan TufailMarcus Fruttiger & Peter M. Maloca. (2018) MACULAR TELANGIECTASIA TYPE 2. Retina 38:1, pages S97-S104.
Crossref
Crossref
Mali OkadaTjebo F. C. HeerenCatherine A. EganVincent RoccoRoberto Bonelli & Marcus Fruttiger. (2018) EFFECT OF DARK ADAPTATION AND BLEACHING ON BLUE LIGHT REFLECTANCE IMAGING IN MACULAR TELANGIECTASIA TYPE 2. Retina 38:1, pages S89-S96.
Crossref
Crossref
Mali OkadaAnthony G. Robson, Catherine A. Egan, Ferenc B. Sallo, Simona Degli EspostiTjebo F. C. HeerenMarcus FruttigerGraham E. Holder. (2018) ELECTROPHYSIOLOGICAL CHARACTERIZATION OF MACULAR TELANGIECTASIA TYPE 2 AND STRUCTURE–FUNCTION CORRELATION. Retina 38:1, pages S33-S42.
Crossref
Crossref
Ferenc B. SalloIrene LeungMeike ZeimerTraci E. ClemonsAdam M. DubisMarcus FruttigerDaniel PauleikhoffEmily Y. ChewCatherine EganTunde Peto & Alan C. Bird. (2018) ABNORMAL RETINAL REFLECTIVITY TO SHORT-WAVELENGTH LIGHT IN TYPE 2 IDIOPATHIC MACULAR TELANGIECTASIA. Retina 38:1, pages S79-S88.
Crossref
Crossref
Wenlan Zhang & Dilraj S. Grewal. 2018. Vitreoretinal Disorders. Vitreoretinal Disorders
91
131
.
Mahima Jhingan, Kerul Marsonia, Dhananjay Shukla, Philip J. Rosenfeld & Jay Chhablani. (2017) Idiopathic macular telangiectasis type 2 and co-existent diabetic retinopathy. International Journal of Retina and Vitreous 3:1.
Crossref
Crossref
Varun Chandra, Rohan Merani, Alex P. Hunyor, I-Van Ho & Mark Gillies. (2017) Macular Telangiectasia Type 2 With Spontaneous Resolution of Intraretinal/Sub-Internal Limiting Membrane Hemorrhage in the Absence of Neovascularization. Journal of VitreoRetinal Diseases 1:6, pages 415-419.
Crossref
Crossref
Durgasri Jaisankar, Harshal Gondhale, Jay Chhablani, Manisha Agarwal & Rajiv Raman. (2017) Funduscopic and Angiographic Characteristics in Early and Late Macular Telangiectasia Type 2. Journal of VitreoRetinal Diseases 1:6, pages 372-378.
Crossref
Crossref
Hemal Mehta, Simone Müller, Catherine A Egan, Simona Degli Esposti, Adnan Tufail, Dawn A Sim, Frank G Holz, Andrew C Browning, Winfried M Amoaku, Peter Charbel Issa & Mark C Gillies. (2017) Natural history and effect of therapeutic interventions on subretinal fluid causing foveal detachment in macular telangiectasia type 2. British Journal of Ophthalmology 101:7, pages 955-959.
Crossref
Crossref
Thomas S Scerri, Anna Quaglieri, Carolyn Cai, Jana Zernant, Nori Matsunami, Lisa Baird, Lea Scheppke, Roberto Bonelli, Lawrence A Yannuzzi, Martin Friedlander, Catherine A Egan, Marcus Fruttiger, Mark Leppert, Rando Allikmets & Melanie Bahlo. (2017) Genome-wide analyses identify common variants associated with macular telangiectasia type 2. Nature Genetics 49:4, pages 559-567.
Crossref
Crossref
Anna Elias, Mahesh Gopalakrishnan & Giridhar Anantharaman. (2017) Risk factors in patients with macular telangiectasia 2A in an Asian population: A case–control study. Indian Journal of Ophthalmology 65:9, pages 830.
Crossref
Crossref
Peter Charbel Issa, Simone Müller, Tjebo F. C. Heeren & Frank G. Holz. 2017. Spectral Domain Optical Coherence Tomography in Macular Diseases. Spectral Domain Optical Coherence Tomography in Macular Diseases
217
225
.
Lavanya Chidambara, Santosh G K Gadde, Naresh Kumar Yadav, Chaitra Jayadev, Devanshi Bhanushali, Abhishek M Appaji, Mukunda Akkali, Aruj Khurana & Rohit Shetty. (2016) Characteristics and quantification of vascular changes in macular telangiectasia type 2 on optical coherence tomography angiography. British Journal of Ophthalmology 100:11, pages 1482-1488.
Crossref
Crossref
Okan Toygar, Matthew G. Guess, David S. Youssef & Daniel M. Miller. (2016) LONG-TERM OUTCOMES OF INTRAVITREAL BEVACIZUMAB THERAPY FOR SUBRETINAL NEOVASCULARIZATION SECONDARY TO IDIOPATHIC MACULAR TELANGIECTASIA TYPE 2. Retina 36:11, pages 2150-2157.
Crossref
Crossref
Nora Khatib & Robert E. CoffeeIIIIII. 2016. Vascular Lesions of the Orbit and Face. Vascular Lesions of the Orbit and Face
19
29
.
Lihteh Wu. (2015) When is macular edema not macular edema? An update on macular telangiectasia type 2. Taiwan Journal of Ophthalmology 5:4, pages 149-155.
Crossref
Crossref
Qinqin Zhang, Ruikang K. Wang, Chieh-Li Chen, Andrew D. Legarreta, Mary K. Durbin, Lin An, Utkarsh Sharma, Paul F. Stetson, John E. Legarreta, Luiz Roisman, Giovanni Gregori & Philip J. Rosenfeld. (2015) SWEPT SOURCE OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY OF NEOVASCULAR MACULAR TELANGIECTASIA TYPE 2. Retina 35:11, pages 2285-2299.
Crossref
Crossref
Ferenc B. Sallo, Irene Leung, Traci E. Clemons, Tunde Peto, Alan C. Bird & Daniel Pauleikhoff. (2015) MULTIMODAL IMAGING IN TYPE 2 IDIOPATHIC MACULAR TELANGIECTASIA. Retina 35:4, pages 742-749.
Crossref
Crossref
João P. Monteiro, Fátima M. Santos, Ana S. Rocha, João P. Castro‐de‐Sousa, João A. Queiroz, Luis A. Passarinha & Cândida T. Tomaz. (2015) Vitreous humor in the pathologic scope: Insights from proteomic approaches. PROTEOMICS – Clinical Applications 9:1-2, pages 187-202.
Crossref
Crossref
Lihteh Wu. (2015) Multimodality imaging in macular telangiectasia 2: A clue to its pathogenesis. Indian Journal of Ophthalmology 63:5, pages 394.
Crossref
Crossref
Julie Jacob, Michel Paques, Valérie Krivosic, Bénédicte Dupas, Aude Couturier, Caroline Kulcsar, Ramin Tadayoni, Pascale Massin & Alain Gaudric. (2015) Meaning of Visualizing Retinal Cone Mosaic on Adaptive Optics Images. American Journal of Ophthalmology 159:1, pages 118-123.e1.
Crossref
Crossref
Mariana R. Thorell, Qinqin Zhang, Yanping Huang, Lin An, Mary K. Durbin, Michal Laron, Utkarsh Sharma, Paul F. Stetson, Giovanni Gregori, Ruikang K. Wang & Philip J. Rosenfeld. (2014) Swept-Source OCT Angiography of Macular Telangiectasia Type 2. Ophthalmic Surgery, Lasers and Imaging Retina 45:5, pages 369-380.
Crossref
Crossref
T.F.C. Heeren, E. Krüger, F.G. Holz & P. Charbel Issa. (2014) Funktionelle Charakteristika bei makulären Teleangiektasien Typ 2Functional characteristics of macular telangiectasia type 2. Der Ophthalmologe 111:9, pages 829-833.
Crossref
Crossref
Konstantinos Balaskas, Irene Leung, Ferenc B. Sallo, Traci E. Clemons, Alan C. Bird & Tunde Peto. (2014) ASSOCIATIONS BETWEEN AUTOFLUORESCENCE ABNORMALITIES AND VISUAL ACUITY IN IDIOPATHIC MACULAR TELANGIECTASIA TYPE 2. Retina 34:8, pages 1630-1636.
Crossref
Crossref
Tjebo F. C. Heeren, Frank G. Holz & Peter Charbel Issa. (2014) FIRST SYMPTOMS AND THEIR AGE OF ONSET IN MACULAR TELANGIECTASIA TYPE 2. Retina 34:5, pages 916-919.
Crossref
Crossref
Jay Chhablani, Kopal Mithal, Harsha Rao & Raja Narayanan. (2013) Diagnosis of subretinal neovascularization associated with idiopathic juxtafoveal retinal telangiectasia — fluorescein angiography versus spectral-domain optical coherence tomography. Graefe's Archive for Clinical and Experimental Ophthalmology 252:4, pages 549-553.
Crossref
Crossref
Tjebo F. C. Heeren, Frank G. Holz & Peter Charbel Issa. 2014. Microperimetry and Multimodal Retinal Imaging. Microperimetry and Multimodal Retinal Imaging
111
118
.
Lihteh Wu, Teodoro Evans & J. Fernando Arevalo. (2013) Idiopathic macular telangiectasia type 2 (idiopathic juxtafoveolar retinal telangiectasis type 2A, Mac Tel 2). Survey of Ophthalmology 58:6, pages 536-559.
Crossref
Crossref
Michael B. Powner, Mark C. Gillies, Meidong Zhu, Kristis Vevis, Alex P. Hunyor & Marcus Fruttiger. (2013) Loss of Müller's Cells and Photoreceptors in Macular Telangiectasia Type 2. Ophthalmology 120:11, pages 2344-2352.
Crossref
Crossref
Tobias Meyer-ter-Vehn, Sina Herzog, Marc Schargus, Winfried Göbel & Rainer Guthoff. (2013) Long-term course in type 2 idiopathic macular telangiectasia. Graefe's Archive for Clinical and Experimental Ophthalmology 251:11, pages 2513-2520.
Crossref
Crossref
Peter Charbel Issa, Mark C. Gillies, Emily Y. Chew, Alan C. Bird, Tjebo F.C. Heeren, Tunde Peto, Frank G. Holz & Hendrik P.N. Scholl. (2013) Macular telangiectasia type 2. Progress in Retinal and Eye Research 34, pages 49-77.
Crossref
Crossref
Raja Narayanan, Vivek Dave, Padmaja K. Rani, Jay Chhablani, Harsha B. Rao, Rajeev R. Pappuru & Subhadra Jalali. (2012) Multifocal electroretinography in type 2 idiopathic macular telangiectasia. Graefe's Archive for Clinical and Experimental Ophthalmology 251:5, pages 1311-1318.
Crossref
Crossref
Annal D. Meleth, Brian C. Toy, Divya Nigam, Elvira Agrón, Robert P. Murphy, Emily Y. Chew & Wai T. Wong. (2013) PREVALENCE AND PROGRESSION OF PIGMENT CLUMPING ASSOCIATED WITH IDIOPATHIC MACULAR TELANGIECTASIA TYPE 2. Retina 33:4, pages 762-770.
Crossref
Crossref
Michael Engelbert & Lawrence A. Yannuzzi. (2018) Idiopathic Macular Telangiectasia Type 2: The Progressive Vasculopathy. European Journal of Ophthalmology 23:1, pages 1-6.
Crossref
Crossref
Michael Engelbert, Emily Y. Chew & Lawrence A. Yannuzzi. 2013. Retina. Retina
1050
1057
.
Jay Kumar Chhablani & Raja Narayanan. (2011) Fundus autofluorescence patterns in type 2A idiopathic juxtafoveolar retinal telangiectasis. European Journal of Ophthalmology 22:3, pages 398-403.
Crossref
Crossref
Brian C. Toy, Euna Koo, Catherine Cukras, Catherine B. Meyerle, Emily Y. Chew & Wai T. Wong. (2012) TREATMENT OF NONNEOVASCULAR IDIOPATHIC MACULAR TELANGIECTASIA TYPE 2 WITH INTRAVITREAL RANIBIZUMAB. Retina 32:5, pages 996-1006.
Crossref
Crossref
Alice C. L. Len, Michael B. PownerLing Zhu, Gregory S. Hageman, Xiaomin Song, Marcus FruttigerMark C. Gillies. (2011) Pilot Application of iTRAQ to the Retinal Disease Macular Telangiectasia. Journal of Proteome Research 11:2, pages 537-553.
Crossref
Crossref
Dhananjay Shukla, Shashank R. Gupta, Nithya Neelakantan, Sachin Tiwari, Sumi Gupta, Aditi R. Patwardhan & Thayyil B. Soubhya. (2012) TYPE 2 IDIOPATHIC MACULAR TELANGIECTASIA. Retina 32:2, pages 265-274.
Crossref
Crossref
Antonia M. JoussenAntonia M. Joussen. 2012. Retinale Gefäßerkrankungen. Retinale Gefäßerkrankungen
243
303
.
Melanie Frances Larizza, Jing Xie, Eva Fenwick, Ecosse Luc Lamoureux, Jill Elizabeth Keeffe & Gwyneth Rees. (2011) Impact of a Low-Vision Self-Management Program on Informal Caregivers. Optometry and Vision Science 88:12, pages 1486-1495.
Crossref
Crossref
Ferenc B. Sallo, Irene Leung, Mina Chung, Ute E.K. Wolf-Schnurrbusch, Alfredo Dubra, David R. Williams, Traci Clemons, Daniel Pauleikhoff, Alan C. Bird & Tunde Peto. (2011) Retinal Crystals in Type 2 Idiopathic Macular Telangiectasia. Ophthalmology 118:12, pages 2461-2467.
Crossref
Crossref
Jost B. Jonas, Teodosio Libondi, Stefan von Baltz & Sven Beutelspacher. (2011) Intravitreal bevacizumab for perifoveal telangiectasia. Acta Ophthalmologica 89:7, pages e607-e608.
Crossref
Crossref
A Brock Roller, James C Folk, Narendra M Patel, H Culver Boldt, Stephen R Russell, Michael D Abramoff & Vinit B Mahajan. (2011) INTRAVITREAL BEVACIZUMAB FOR TREATMENT OF PROLIFERATIVE AND NONPROLIFERATIVE TYPE 2 IDIOPATHIC MACULAR TELANGIECTASIA. Retina 31:9, pages 1848-1855.
Crossref
Crossref
Peter Charbel Issa, Robert P. Finger, Kathrin Kruse, Sönke Baumüller, Hendrik P.N. Scholl & Frank G. Holz. (2011) Monthly Ranibizumab for Nonproliferative Macular Telangiectasia Type 2: A 12-Month Prospective Study. American Journal of Ophthalmology 151:5, pages 876-886.e1.
Crossref
Crossref